AcuCort wins renewed FDA small business waiver for planned NDA fee exemption

• AcuCort won a renewed FDA Small Business Waiver, removing the planned NDA application fee of about SEK 16 million.
• The company remains on track to file its NDA later this year; FDA review typically takes about 12 months.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. AcuCort AB published the original content used to generate this news brief via Cision (Ref. ID: 202607270210BITN____UKPR__EN_20260726-BIT-1860-0) on July 27, 2026, and is solely responsible for the information contained therein.